breast cancer

Roche shares spike as PhIII breast cancer combo with Perjeta scores a success, Puma takes a beating
Endpoints
Thu, 03/2/17 - 10:41 am
Roche
breast cancer
clinical trials
Perjeta
Clovis, Tesaro Soar on Astrazeneca Phase Three News
TheStreet.com
Sat, 02/18/17 - 02:37 pm
Clovis Oncology
Tesaro
AstraZeneca
clinical trials
Lynparza
breast cancer
AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial
TheStreet.com
Fri, 02/17/17 - 11:02 am
AstraZeneca
Lynparza
breast cancer
Tesaro sees a $5B market opportunity for its cancer drug
Bizjournals.com
Fri, 02/17/17 - 10:14 am
Tesaro
niraparib
ovarian cancer
breast cancer
UK cost watchdog says Pfizer's Ibrance too pricey
BioPharma Dive
Tue, 02/7/17 - 10:21 am
UK
Pfizer
Ibrance
drug pricing
breast cancer
Galena Biopharma stock surges 21% after independent group says breast cancer drug has no safety concerns
Marketwatch
Mon, 02/6/17 - 11:13 am
Galena Biopharma
breast cancer
NeuVax
clinical trials
Roche Has Aphinity For Perjeta Trial Success, But Not Puma
Seeking Alpha
Sun, 01/8/17 - 03:28 pm
Roche
Perjeta
Puma Biotechnology
breast cancer
How Could Pfizer Drive Growth for Ibrance?
Market Realist
Mon, 12/12/16 - 02:49 pm
Pfizer
Ibrance
breast cancer
AbbVie breast cancer drug falls short in Phase 2
BioPharma Dive
Wed, 12/7/16 - 07:45 pm
AbbVie
breast cancer
veliparib
PARP inhibitors
BRCA-mutant breast cancer
With new name, new CEO, Cascadian now rolls out a new pivotal plan for lead cancer drug
Endpoints
Wed, 12/7/16 - 10:16 am
Oncothyreon
Cascadian
tucatinib
ONT-380
treatment-resistant breast cancer
breast cancer
Ibrance May Continue to Dominate Breast Cancer Space in 2016
Market Realist
Tue, 11/15/16 - 09:38 am
Ibrance
Pfizer
breast cancer
Pfizer wins EU's approval for Ibrance as Novartis readies rival drug
Yahoo/Reuters
Thu, 11/10/16 - 11:21 am
Pfizer
Europe
Ibrance
breast cancer
Novartis
ribociclib
Novartis Takes Aim at Pfizer
Motley Fool
Thu, 11/3/16 - 09:48 am
Novartis
Pfizer
breast cancer
ribociclib
Ibrance
Pfizer touts Ibrance's safety as competition intensifies
BioPharma Dive
Wed, 11/2/16 - 09:52 am
Pfizer
Ibrance
breast cancer
Pfizer Continues to Work on Ibrance Label Expansion in 2016
Market Realist
Thu, 10/27/16 - 09:14 am
Pfizer
Ibrance
breast cancer
Puma Bio's Desperate Money Grab Signals Breast Cancer Drug Trouble
TheStreet.com
Thu, 10/20/16 - 03:31 pm
Puma Biotechnology
breast cancer
neratinib
Novartis Targets Breast Cancer Drug Approval to Take on Pfizer
Bloomberg
Sat, 10/8/16 - 03:48 pm
Novartis
Pfizer
breast cancer
ribociclib
Puma Biotech Rises on Key FDA Approval
24/7 Wall St
Wed, 09/21/16 - 09:34 am
Puma Biotechnology
FDA
neratinib
breast cancer
Pfizer gets green light for Ibrance in EU
BioPharma Dive
Mon, 09/19/16 - 06:05 pm
Pfizer
Ibrance
Europe
breast cancer
How Pfizer Plans to Extend Ibrance beyond Breast Cancer Treatment
Market Realist
Fri, 09/2/16 - 11:24 am
Pfizer
Ibrance
breast cancer
head and neck cancer
lung cancer
pancreatic cancer

Pages